Removing DEI from study and trial participant selection is tremendously detrimental to the vast majority of patients - who (shocker) are not white males.
#shockednotshocked #DEI
#shockednotshocked #DEI
Reposted from
NPR
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the agency's website, as the Trump administration halts DEI initiatives.
Comments